4//SEC Filing
Murugan Amar 4
Accession 0001140361-23-010097
CIK 0001604464other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:15 PM ET
Size
7.2 KB
Accession
0001140361-23-010097
Insider Transaction Report
Form 4
Murugan Amar
SVP, GC & Secretary
Transactions
- Award
Common Stock
2023-03-01+155,375→ 283,555 total - Award
Employee Stock Option (Right to Buy)
2023-03-01+349,593→ 349,593 totalExercise: $3.91Exp: 2033-02-28→ Common Stock (349,593 underlying)
Footnotes (3)
- [F1]These restricted stock units vest in 12 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2023, subject to the reporting person's continuous service. "Company Quarterly Vesting Date" means March 1, May 15, August 15 and November 15 of each year.
- [F2]Includes 594 shares purchased under the Issuer's Employee Stock Purchase Plan on November 30, 2022.
- [F3]1/36th of the shares subject to the stock option vest and become exercisable each month, with the initial installment vesting on April 1, 2023, subject to the reporting person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001809916
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:15 PM ET
- Size
- 7.2 KB